Understanding Solventum Corp (SOLV)’s financial health through ratios

Solventum Corp (NYSE: SOLV) closed the day trading at $63.17 down -1.13% from the previous closing price of $63.89. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 2280641 shares were traded.

Ratios:

For a better understanding of SOLV, let’s look at its different ratios.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on April 10, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $70.

On April 08, 2024, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $69.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SOLV now has a Market Capitalization of 10.91B and an Enterprise Value of 18.61B. Its current Enterprise Value per Revenue stands at 2.26 whereas that against EBITDA is 9.12.

Stock Price History:

Over the past 52 weeks, SOLV has reached a high of $96.05, while it has fallen to a 52-week low of $62.33. The 50-Day Moving Average of the stock is 66.28, while the 200-Day Moving Average is calculated to be 66.28.

Shares Statistics:

Over the past 3-months, SOLV traded about 4.67M shares per day on average, while over the past 10 days, SOLV traded about 5.56M shares per day. A total of 172.47M shares are outstanding, with a floating share count of 138.34M. Insiders hold about 19.90% of the company’s shares, while institutions hold 18.35% stake in the company.

Earnings Estimates

Current recommendations for the stock of the company come from 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.

Most Popular

[the_ad id="945"]